Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURE: Adalimumab in Early Rheumatoid Arthritis
NCT00480272Phase 4Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- May 2007
- Primary completion
- Mar 2017
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab, prednisone in rheumatoid arthritis (RA), sponsored by IRCCS San Matteo Foundation. Started May 2007; status: completed.
02
Drugs
adalimumabprednisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00480272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00480272.